
Rachel Black
Adelaide Medical School
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Rachel is a rheumatologist and clinician researcher who completed her PhD in 2019 looking at the epidemiology and patient perspectives of glucocorticoid use and adverse effects in rheumatoid arthritis and other inflammatory diseases. Her interests include pharmacoepidemiology and the use of big data to answer research questions directly relevant to her clinical practice in rheumatology.
-
Appointments
Date Position Institution name 2018 - ongoing Consultant Rheumatologist The Queen Elizabeth Hospital 2016 - ongoing Clinical Lecturer University of Adelaide 2015 - ongoing Consultant Rheumatologist Royal Adelaide Hospital -
Awards and Achievements
Date Type Title Institution Name Country Amount 2015 Scholarship Arthritis SA/Australian Rheumatology Association (SA) Postgraduate Grant 2014 Scholarship Australian Postgraduate Award (The University of Adelaide) The University of Adelaide Australia 2013 Fellowship Ken Muirden Overseas Training Fellowship Arthritis Research UK Centre for Epidemiology, The University of Manchester United Kingdom -
Education
Date Institution name Country Title 2013 - 2019 University of Adelaide Australia PhD 1999 - 2004 University of Adelaide Australia MBBS -
Postgraduate Training
Date Title Institution Country 2007 - 2012 FRACP Royal Australasian College of Physicians Australia -
Research Interests
-
Journals
Year Citation 2021 Rischin, A., Liew, D., Black, R., Fletcher, A., Buchbinder, R., Lassere, M., . . . Sinnathurai, P. (2021). Healthcare access and attitudes towards telehealth during the early phase of the COVID-19 pandemic among an Australian cohort with inflammatory arthritis. Internal Medicine Journal, 51(5), 788-792.
Scopus2 WoS1 Europe PMC12021 Tieu, J., Cheah, J. T., Black, R. J., Christensen, R., Ghosh, N., Richards, P., . . . Hill, C. L. (2021). Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set. Seminars in Arthritis and Rheumatism, 51(5), 1139-1145.
Scopus1 WoS22021 Bryant, M. J., Schubert, J. P., Black, R. J., & Hill, C. L. (2021). Patient-Reported Experience Measures in outpatient rheumatology care: A systematic review. Rheumatology Advances in Practice, 5(3), rkab079.
2020 Ruediger, C., Nguyen, L., Black, R., Proudman, S., & Hill, C. (2020). Efficacy of Methotrexate in Polymyalgia Rheumatica in routine rheumatology clinical care.. Internal medicine journal, 50(9), 1067-1072.
Scopus3 WoS12020 Cheah, J. T., Robson, J. C., Black, R. J., Goodman, S. M., Lester, S., Mackie, S. L., & Hill, C. L. (2020). The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group. Seminars in Arthritis and Rheumatism, 50(5), 996-1005.
Scopus2 WoS4 Europe PMC12019 Cheah, J. T. L., Black, R. J., Robson, J. C., Navarro-Millán, I. Y., Young, S. R., Richards, P., . . . Hill, C. L. (2019). Toward a core domain set for glucocorticoid impact in inflammatory rheumatic diseases: The OMERACT 2018 glucocorticoid impact working group. Journal of Rheumatology, 46(9), 1179-1182.
Scopus5 WoS5 Europe PMC32019 Black, R., Richards, B., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., . . . Hill, C. (2019). Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 49(3), 351-357.
Scopus2 WoS4 Europe PMC12019 Hoon, E., Ruediger, C., Gill, T., Black, R., & Hill, C. (2019). A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis. Open Access Rheumatology : Research and Reviews, 11, 189-198.
Scopus4 Europe PMC32019 Flurey, C. A., Tugwell, P. S., Black, R. J., Halls, S., Page, M. J., Robson, J. C., . . . Richards, B. (2019). The OMERACT Emerging Leaders Program: The Good, the Bad, and the Future. JOURNAL OF RHEUMATOLOGY, 46(8), 1047-1052.
Scopus2 WoS2 Europe PMC22017 Black, R., Robson, J., Goodman, S., Hoon, E., Lai, L., Simon, L., . . . Hill, C. (2017). A patient-reported outcome measure for effect of glucocorticoid therapy in adults with inflammatory diseases is needed: report from the OMERACT 2016 special interest group. Journal of Rheumatology, 44(11), 1754-1758.
Scopus12 WoS11 Europe PMC72017 Mackie, S., Twohig, H., Neill, L., Harrison, E., Shea, B., Black, R., . . . Hill, C. (2017). The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatica. Journal of Rheumatology, 44(10), 1515-1521.
Scopus20 WoS18 Europe PMC112017 Black, R., Goodman, S., Ruediger, C., Lester, S., Mackie, S., & Hill, C. (2017). A survey of glucocorticoid adverse effects and benefits in rheumatic diseases: The patient perspective. Journal of Clinical Rheumatology, 23(8), 416-420.
Scopus12 WoS14 Europe PMC92017 Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Research and Therapy, 19(1), 253-1-253-8.
Scopus11 WoS15 Europe PMC92016 Lester, S., Hewitt, A., Ruediger, C., Bradbury, L., De Smit, E., Wiese, M., . . . Hill, C. (2016). PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis. RMD Open, 2(1), e000246-1-e000246-3.
Scopus7 Europe PMC42016 Hill, C. L., Black, R. J., Nossent, J. C., Ruediger, C., Nguyen, L., Ninan, J. V., & Lester, S. (2016). Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 46(4), 513-519.
Scopus39 WoS41 Europe PMC172016 Black, R., Hill, C., Lester, S., & Dixon, W. (2016). The association between systemic glucocorticoid use and the risk of cataract and glaucoma in patients with rheumatoid arthritis: a systematic review and meta- analysis. PLoS ONE, 11(11), e0166468.
Scopus20 WoS19 Europe PMC82015 Black, R., Joseph, R., Brown, B., Movahedi, M., Lunt, M., & Dixon, W. (2015). Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: A retrospective drug utilisation study. Arthritis Research and Therapy, 17(1), 375.
Scopus23 WoS22 Europe PMC172014 Black, R., Spargo, L., Schultz, C., Chatterton, B., Cleland, L., Lester, S., . . . Proudman, S. (2014). Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis. Arthritis Care & Research, 66(4), 515-522.
Scopus12 WoS12 Europe PMC72014 Dunstan, E., Lester, S., Rischmueller, M., Dodd, T., Black, R., Ahern, M., . . . Hill, C. (2014). Epidemiology of biopsy-proven giant cell arteritis in South Australia. Internal Medicine Journal, 44(1), 32-39.
Scopus45 WoS42 Europe PMC212013 Black, R., Roach, D., Rischmueller, M., Lester, S., & Hill, C. (2013). The use of temporal artery ultrasound in the diagnosis of giant cell arteritis in routine practice. International Journal of Rheumatic Diseases, 16(3), 352-357.
Scopus13 WoS13 Europe PMC82013 Dunstan, E., Lester, S., Black, R., Rischmueller, M., Chan, H., Hewitt, A., & Hill, C. (2013). No association between FCγR3B copy number variation and susceptibility to biopsy-proven giant cell arteritis. Arthritis, 2013, 514914-1-514914-4.
Europe PMC12012 Black, R., Lester, S., Dunstan, E., Shahram, F., Nadji, A., Bayat, N., . . . Davatchi, F. (2012). Fc-gamma receptor 3B copy number variation is not a risk factor for Behçet’s disease. International Journal of Rheumatology, 2012, 1-4.
Scopus5 Europe PMC42011 Black, R., Limaye, V., & Cleland, L. (2011). Acute Monoarthritis: What should one do?. Medicine Today: the peer reviewed journal of clinical practice, 12(3), 49-55. -
Conference Papers
Year Citation 2021 Bridgewater, S., Dawson, J., Ndosi, M., Black, R. J., Cheah, T. L., Dures, E., . . . Robson, J. (2021). DEVELOPMENT OF A CONCEPTUAL FRAMEWORK FOR A PATIENT REPORTED OUTCOME MEASURE TO CAPTURE PATIENTS' PERCEPTIONS OF GLUCOCORTICOID THERAPY DURING TREATMENT FOR RHEUMATIC DISEASES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 1441). Virtual Congress: BMJ PUBLISHING GROUP.
WoS12015 Black, R. J., Joseph, R. M., Movahedi, M., Lunt, M., & Dixon, W. G. (2015). PRESCRIBER INFLUENCE ON ORAL GLUCOCORTICOID PRESCRIBING IN UK PRIMARY CARE FOR PATIENTS WITH RHEUMATOID ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 1291). BMJ PUBLISHING GROUP.
2015 Black, R. J., Joseph, R. M., Movahedi, M., Lunt, M., & Dixon, W. G. (2015). Oral Glucocorticoid Prescribing Patterns in UK Primary Care for Patients with Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 67 (pp. 2 pages). WILEY-BLACKWELL. -
Conference Items
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2022 Co-Supervisor The influence of socioeconomic factors on medication use and health outcomes in Australians with rheumatoid arthritis Master of Clinical Science Master Part Time Oscar Kenneth Russell 2021 Co-Supervisor Patient Reported Experience Measures in Australian outpatient rheumatology care Master of Philosophy (Clinical Science) Master Full Time Dr Madeleine Bryant
Connect With Me
External Profiles